Takumi Kishimoto Selected Research

Takumi Kishimoto Research Topics

Disease

43	Malignant Mesothelioma 01/2022 - 04/2003
26	Neoplasms (Cancer) 01/2022 - 04/2003
19	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2003
17	Mesothelioma 01/2022 - 04/2006
13	Pleural Effusion (Pleural Effusions) 10/2022 - 08/2005
10	Asbestosis 05/2016 - 10/2006
7	Pleurisy (Pleuritis) 01/2020 - 09/2008
7	Silicosis 03/2018 - 05/2006
5	Fibrosis (Cirrhosis) 01/2022 - 03/2011
4	Inflammation (Inflammations) 12/2019 - 03/2011
4	Adenocarcinoma 08/2017 - 12/2009
3	Pulmonary Atelectasis 04/2018 - 02/2002
3	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 10/2011 - 10/2006
2	Pneumonia (Pneumonitis) 02/2022 - 03/2009
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 11/2019
2	Emphysema 01/2022 - 04/2018
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 11/2004
2	Disease Progression 06/2019 - 01/2018
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2018 - 01/2015
2	Lymphoma (Lymphomas) 09/2018 - 01/2015
2	Carcinoma (Carcinomatosis) 02/2017 - 01/2017
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2016 - 09/2011
2	Adenocarcinoma of Lung 11/2015 - 12/2009
2	Autoimmune Diseases (Autoimmune Disease) 01/2012 - 09/2011
2	Neoplasm Metastasis (Metastasis) 03/2004 - 05/2002
2	Pulmonary Edema 04/2003 - 04/2003
1	Lymphopenia (Lymphocytopenia) 02/2022
1	Hematuria 02/2022
1	Lupus Nephritis 02/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2022
1	Communicable Diseases (Infectious Diseases) 02/2022
1	Infections 02/2022
1	Leukopenia 02/2022
1	Proteinuria 02/2022
1	Hyperglycemia 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Myasthenia Gravis 01/2022
1	Pneumothorax 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Lung Injury 11/2019
1	Rare Diseases (Rare Disease) 04/2019
1	Antisynthetase syndrome 09/2018
1	Hyperplasia 03/2018

Drug/Important Bio-Agent (IBA)

43	AsbestosIBA 10/2022 - 02/2002
5	Silicon Dioxide (Silica)FDA LinkGeneric 02/2022 - 09/2008
4	Proteins (Proteins, Gene)FDA Link 08/2017 - 08/2005
3	Monoclonal AntibodiesIBA 01/2022 - 11/2019
3	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 06/2013
3	MesothelinIBA 01/2021 - 03/2010
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2011
3	Pemetrexed (MTA)FDA Link 01/2018 - 12/2011
3	1-methyl-1-piperidinomethane sulfonateIBA 11/2015 - 11/2008
3	DNA (Deoxyribonucleic Acid)IBA 11/2015 - 04/2006
3	MicroRNAs (MicroRNA)IBA 12/2013 - 08/2011
2	NivolumabIBA 06/2021 - 01/2018
2	Cell-Free Nucleic AcidsIBA 06/2019 - 12/2013
2	SurvivinIBA 03/2018 - 05/2006
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 05/2017
2	Messenger RNA (mRNA)IBA 08/2017 - 11/2006
2	ParaffinIBA 08/2017 - 01/2017
2	Formaldehyde (Formol)FDA Link 08/2017 - 01/2017
2	Claudin-4IBA 02/2017 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2012 - 03/2009
2	Carboplatin (JM8)FDA LinkGeneric 01/2012 - 12/2011
2	Serpentine Asbestos (Chrysotile)IBA 09/2011 - 10/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2011 - 11/2006
2	CytokinesIBA 07/2009 - 08/2007
1	anti-dsDNA autoantibodyIBA 02/2022
1	Antiviral Agents (Antivirals)IBA 02/2022
1	CreatinineIBA 02/2022
1	durvalumabIBA 01/2022
1	acrylic acid (acrylate)IBA 01/2022
1	tremelimumabIBA 01/2022
1	PolymersIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2021
1	Galectin 3 (LGALS3)IBA 01/2021
1	Secretory Leukocyte Peptidase InhibitorIBA 01/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2019
1	ChemokinesIBA 12/2019
1	LigandsIBA 12/2019
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 11/2019
1	Glycoproteins (Glycoprotein)IBA 11/2019
1	Pharmaceutical PreparationsIBA 11/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2018
1	Tacrolimus (Prograf)FDA LinkGeneric 09/2018
1	Methotrexate (Mexate)FDA LinkGeneric 09/2018
1	tremolite (bredigite)IBA 09/2017
1	RNA (Ribonucleic Acid)IBA 08/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2017

Therapy/Procedure

9	Therapeutics 02/2022 - 03/2004
8	Drug Therapy (Chemotherapy) 05/2017 - 05/2002
4	Radiotherapy 01/2016 - 05/2002
2	Chemoradiotherapy 05/2017 - 03/2011
2	Pneumonectomy (Lung Volume Reduction) 05/2016 - 01/2015
1	Immunotherapy 11/2019
1	Traction 04/2018
1	Pleurodesis 03/2018
1	Length of Stay 03/2018
1	Chest Tubes (Chest Tube) 03/2018
1	Combination Drug Therapy (Combination Chemotherapy) 01/2018